Table 10.
Relative potencies (RPs) for TTX analogues, as determined in the Neuro2a‐assay
Compound | EC50 (nM) | RP | Reference |
---|---|---|---|
TTX |
2.1 4.6 4.7 |
1 |
Kudo et al. (2014) Yotsu‐Yamashita et al. (2003) Saruhashi et al. (2016) |
11‐deoxyTTX |
130 270 |
0.016 0.017 |
Kudo et al. (2014) Yotsu‐Yamashita et al. (2003) |
6,11‐dideoxyTTX | 400 | 0.056 | Kudo et al. (2014) |
11‐oxoTTX | 2.9 | 1.6 | Saruhashi et al. (2016) |
6‐deoxyTTX | 6.5 | 0.32 | Kudo et al. (2014) |
EC50: Effective concentration 50%.